Small-scale studies of nine cases (abstract 1191, AACR Annual Meeting 2019) and two cases [46] reported a better survival for patients with PD-L1-positive NUT carcinoma even though these patients did not receive immunotherapy. Here, CD274 is linked to nut midline carcinoma.